Open an account

Cosmos Health

COSM · NASDAQ

$0.261+$0.008 (+3.16%)TodayMarket closed ·
Prev close $0.253

About COSM

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Thessaloniki, Central Macedonia and currently employs 163 full-time employees. The company went IPO on 2010-05-19. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Employees
163
Headquarters
Thessaloniki, Central Macedonia
Listed
May 19, 2010
Sector
Health Care
Industry
Health Care Providers & Services
Website
cosmosholdingsinc.com

COSM key statistics

Market cap
26.27M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.12M
Volume
2.68M
Open price
$0.2675
High today
$0.2774
Low today
$0.2427
52 Week high
$1.07
52 Week low
$0.1616

Cosmos Health (COSM) at a glance

As of Oct 23, 2026, Cosmos Health (COSM) shares are priced at $0.261, giving the company a market cap of 26.27M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.2427 and $0.2774. The current price is 7.5% above the day's low and 5.9% below its high.

Volume so far is 2.68M shares, in line with the average of 3.12M shares a day.

Over the past year Cosmos Health has ranged from $0.1616 to $1.07, and now sits 11% of the way up that range.

Cosmos Health met or beat analyst EPS estimates in 1 of the last 7 quarters. In Q2 FY26 it reported -$0.10 per share against an estimate of $0.0102.

COSM earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 7 quarters, by 23.0% on average.

  1. Q4 FY23: reported -$1.73 per share against an estimate of -$0.204
  2. Q1 FY24: reported -$0.11 per share against an estimate of -$0.1428
  3. Q2 FY24: reported -$0.15 per share against an estimate of -$0.1428
  4. Q3 FY24: reported -$0.45 per share against an estimate of -$0.1122
  5. Q4 FY25: reported -$0.31 per share against an estimate of -$0.0408
  6. Q1 FY26: reported -$0.06 per share against an estimate of -$0.0102
  7. Q2 FY26: reported -$0.10 per share against an estimate of $0.0102

COSM news

  • Press releaseACCESS Newswire

    Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway

  • Press releaseACCESS Newswire

    Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion

  • Press releaseACCESS Newswire

    Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days

  • Press releaseACCESS Newswire

    Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription

  • Press releaseACCESS Newswire

    Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days

  • Press releaseACCESS Newswire

    Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million

  • Press releaseACCESS Newswire

    Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion

  • Press releaseACCESS Newswire

    Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.